{
"info": {
"nct_id": "NCT03912831",
"official_title": "A Phase 1 Study Evaluating the Safety and Efficacy of HPV16 E7 T Cell Receptor Engineered T Cells (KITE-439) in HLA-A*02:01+ Subjects With Relapsed/Refractory HPV16+ Cancers",
"inclusion_criteria": "* Advanced cancer defined as relapsed or refractory disease after at least 1 line of therapy that included systemic chemotherapy and that is not amenable to definitive locoregional therapy\n* HPV16+ tumor as confirmed by the central laboratory\n* HLA type is HLA-A*02:01+ per local assessment\n* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1\n\nKey\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Presence of fungal, bacterial, viral, or other infection requiring anti-microbials for management\n\n * Note: Simple urinary tract infection (UTI) and uncomplicated bacterial pharyngitis are permitted if responding to active treatment and after consultation with the Kite medical monitor\n* Primary immunodeficiency\n* History of autoimmune disease (eg, Crohns, rheumatoid arthritis, systemic lupus) resulting in end organ injury or requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollment\n* Known history of infection with human immunodeficiency virus (HIV), hepatitis B (HBsAg positive), or hepatitis C (anti-HCV positive). A history of treated hepatitis B or hepatitis C is permitted if the viral load is undetectable per quantitative polymerase chain reaction (qPCR) and/or nucleic acid testing\n\nNote: Other protocol defined Inclusion/Exclusion criteria may apply.",
"miscellaneous_criteria": "Key"
},
"inclusion_lines": [
{
"identified_line": {
"line": "* Advanced cancer defined as relapsed or refractory disease after at least 1 line of therapy that included systemic chemotherapy and that is not amenable to definitive locoregional therapy",
"criterions": [
{
"exact_snippets": "Advanced cancer",
"criterion": "cancer stage",
"requirement": {
"requirement_type": "severity",
"expected_value": "advanced"
}
},
{
"exact_snippets": "relapsed or refractory disease",
"criterion": "disease status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"relapsed",
"refractory"
]
}
},
{
"exact_snippets": "after at least 1 line of therapy",
"criterion": "previous therapy",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "line of therapy"
}
}
},
{
"exact_snippets": "included systemic chemotherapy",
"criterion": "previous therapy type",
"requirement": {
"requirement_type": "type",
"expected_value": "systemic chemotherapy"
}
},
{
"exact_snippets": "not amenable to definitive locoregional therapy",
"criterion": "treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Advanced cancer",
"criterion": "cancer stage",
"requirement": {
"requirement_type": "severity",
"expected_value": "advanced"
}
},
{
"exact_snippets": "relapsed or refractory disease",
"criterion": "disease status",
"requirement": {
"requirement_type": "status",
"expected_value": [
"relapsed",
"refractory"
]
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "after at least 1 line of therapy",
"criterion": "previous therapy",
"requirement": {
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1,
"unit": "line of therapy"
}
}
},
{
"exact_snippets": "included systemic chemotherapy",
"criterion": "previous therapy type",
"requirement": {
"requirement_type": "type",
"expected_value": "systemic chemotherapy"
}
}
]
}
]
},
{
"exact_snippets": "not amenable to definitive locoregional therapy",
"criterion": "treatment options",
"requirement": {
"requirement_type": "availability",
"expected_value": false
}
}
]
}
},
{
"identified_line": {
"line": "* HPV16+ tumor as confirmed by the central laboratory",
"criterions": [
{
"exact_snippets": "HPV16+ tumor",
"criterion": "HPV16+ tumor",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "confirmed by the central laboratory",
"criterion": "confirmation by central laboratory",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "HPV16+ tumor",
"criterion": "HPV16+ tumor",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
},
{
"exact_snippets": "confirmed by the central laboratory",
"criterion": "confirmation by central laboratory",
"requirement": {
"requirement_type": "confirmation",
"expected_value": true
}
}
]
}
},
{
"identified_line": {
"line": "* HLA type is HLA-A*02:01+ per local assessment",
"criterions": [
{
"exact_snippets": "HLA type is HLA-A*02:01+",
"criterion": "HLA type",
"requirement": {
"requirement_type": "specific type",
"expected_value": "HLA-A*02:01+"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "HLA type is HLA-A*02:01+",
"criterion": "HLA type",
"requirement": {
"requirement_type": "specific type",
"expected_value": "HLA-A*02:01+"
}
}
]
}
},
{
"identified_line": {
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirement": {
"requirement_type": "status",
"expected_value": "healthy"
}
}
]
}
},
{
"identified_line": {
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirement": {
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
}
]
}
},
{
"identified_line": {
"line": "Key",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
}
],
"exclusion_lines": [
{
"identified_line": {
"line": "* Primary immunodeficiency",
"criterions": [
{
"exact_snippets": "Primary immunodeficiency",
"criterion": "primary immunodeficiency",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Primary immunodeficiency",
"criterion": "primary immunodeficiency",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
},
{
"identified_line": {
"line": "* History of autoimmune disease (eg, Crohns, rheumatoid arthritis, systemic lupus) resulting in end organ injury or requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollment",
"criterions": [
{
"exact_snippets": "History of autoimmune disease (eg, Crohns, rheumatoid arthritis, systemic lupus)",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "resulting in end organ injury",
"criterion": "end organ injury",
"requirement": {
"requirement_type": "result_of_autoimmune_disease",
"expected_value": true
}
},
{
"exact_snippets": "requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollment",
"criterion": "systemic immunosuppression/systemic disease modifying agents",
"requirement": {
"requirement_type": "requirement_for_autoimmune_disease",
"expected_value": true
}
},
{
"exact_snippets": "requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollment",
"criterion": "systemic immunosuppression/systemic disease modifying agents",
"requirement": {
"requirement_type": "time_frame",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "years"
}
}
}
]
},
"logical_structure": {
"and_criteria": [
{
"and_criteria": [
{
"and_criteria": [
{
"exact_snippets": "History of autoimmune disease (eg, Crohns, rheumatoid arthritis, systemic lupus)",
"criterion": "autoimmune disease",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "resulting in end organ injury",
"criterion": "end organ injury",
"requirement": {
"requirement_type": "result_of_autoimmune_disease",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollment",
"criterion": "systemic immunosuppression/systemic disease modifying agents",
"requirement": {
"requirement_type": "requirement_for_autoimmune_disease",
"expected_value": true
}
},
{
"exact_snippets": "requiring systemic immunosuppression/systemic disease modifying agents within the last 2 years prior to enrollment",
"criterion": "systemic immunosuppression/systemic disease modifying agents",
"requirement": {
"requirement_type": "time_frame",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "years"
}
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "* Known history of infection with human immunodeficiency virus (HIV), hepatitis B (HBsAg positive), or hepatitis C (anti-HCV positive). A history of treated hepatitis B or hepatitis C is permitted if the viral load is undetectable per quantitative polymerase chain reaction (qPCR) and/or nucleic acid testing",
"criterions": [
{
"exact_snippets": "Known history of infection with human immunodeficiency virus (HIV)",
"criterion": "HIV infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "Known history of infection with ... hepatitis B (HBsAg positive)",
"criterion": "hepatitis B infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "Known history of infection with ... hepatitis C (anti-HCV positive)",
"criterion": "hepatitis C infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"exact_snippets": "A history of treated hepatitis B ... if the viral load is undetectable per quantitative polymerase chain reaction (qPCR) and/or nucleic acid testing",
"criterion": "treated hepatitis B",
"requirement": {
"requirement_type": "viral load",
"expected_value": "undetectable"
}
},
{
"exact_snippets": "A history of treated ... hepatitis C is permitted if the viral load is undetectable per quantitative polymerase chain reaction (qPCR) and/or nucleic acid testing",
"criterion": "treated hepatitis C",
"requirement": {
"requirement_type": "viral load",
"expected_value": "undetectable"
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"or_criteria": [
{
"and_criteria": [
{
"exact_snippets": "Known history of infection with human immunodeficiency virus (HIV)",
"criterion": "HIV infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Known history of infection with ... hepatitis B (HBsAg positive)",
"criterion": "hepatitis B infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"not_criteria": {
"exact_snippets": "A history of treated hepatitis B ... if the viral load is undetectable per quantitative polymerase chain reaction (qPCR) and/or nucleic acid testing",
"criterion": "treated hepatitis B",
"requirement": {
"requirement_type": "viral load",
"expected_value": "undetectable"
}
}
}
]
},
{
"and_criteria": [
{
"exact_snippets": "Known history of infection with ... hepatitis C (anti-HCV positive)",
"criterion": "hepatitis C infection",
"requirement": {
"requirement_type": "history",
"expected_value": true
}
},
{
"not_criteria": {
"exact_snippets": "A history of treated ... hepatitis C is permitted if the viral load is undetectable per quantitative polymerase chain reaction (qPCR) and/or nucleic acid testing",
"criterion": "treated hepatitis C",
"requirement": {
"requirement_type": "viral load",
"expected_value": "undetectable"
}
}
}
]
}
]
}
]
}
},
{
"identified_line": {
"line": "Note: Other protocol defined Inclusion/Exclusion criteria may apply.",
"criterions": [
{
"exact_snippets": "Other protocol defined Inclusion/Exclusion criteria",
"criterion": "protocol defined Inclusion/Exclusion criteria",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
]
},
"logical_structure": {
"not_criteria": {
"exact_snippets": "Other protocol defined Inclusion/Exclusion criteria",
"criterion": "protocol defined Inclusion/Exclusion criteria",
"requirement": {
"requirement_type": "presence",
"expected_value": true
}
}
}
}
],
"miscellaneous_lines": [
{
"identified_line": {
"line": "Key",
"criterions": []
},
"logical_structure": {
"and_criteria": []
}
}
],
"failed_inclusion": [
{
"identified_line": {
"line": "* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
}
]
},
"logical_structure": {
"or_criteria": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": "0"
}
},
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1",
"criterion": "ECOG performance status",
"requirement": {
"requirement_type": "value",
"expected_value": "1"
}
}
]
}
}
],
"failed_exclusion": [
{
"identified_line": {
"line": "* Presence of fungal, bacterial, viral, or other infection requiring anti-microbials for management",
"criterions": [
{
"exact_snippets": "Presence of fungal, bacterial, viral, or other infection requiring anti-microbials for management",
"criterion": "infection",
"requirement": {
"requirement_type": "type",
"expected_value": [
"fungal",
"bacterial",
"viral",
"other"
]
}
},
{
"exact_snippets": "Presence of fungal, bacterial, viral, or other infection requiring anti-microbials for management",
"criterion": "infection",
"requirement": {
"requirement_type": "management",
"expected_value": "requiring anti-microbials"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
},
{
"identified_line": {
"line": "* Note: Simple urinary tract infection (UTI) and uncomplicated bacterial pharyngitis are permitted if responding to active treatment and after consultation with the Kite medical monitor",
"criterions": [
{
"exact_snippets": "Simple urinary tract infection (UTI) ... are permitted if responding to active treatment",
"criterion": "simple urinary tract infection (UTI)",
"requirement": {
"requirement_type": "response to treatment",
"expected_value": "responding to active treatment"
}
},
{
"exact_snippets": "uncomplicated bacterial pharyngitis ... are permitted if responding to active treatment",
"criterion": "uncomplicated bacterial pharyngitis",
"requirement": {
"requirement_type": "response to treatment",
"expected_value": "responding to active treatment"
}
}
]
},
"logical_structure": {
"exact_snippets": "failed",
"criterion": "failed",
"requirement": {
"requirement_type": "failed",
"expected_value": "failed"
}
}
}
],
"failed_miscellaneous": []
}